-
-
-
-
-
-
-
Raymond James Reiterates Strong Buy Rating on Edgewise Therapeutics (EWTX)
-
-
-
-
-
-
-
Edgewise Therapeutics, Inc. (EWTX) Tops Q3 EPS by 1c
-
-
-
-
-
-
-
Edgewise Therapeutics, Inc. (EWTX) Misses Q4 EPS by 4c
-
-
-
-
-
-
-
Edgewise Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlights
-
-
-
-
-
-
-
Edgewise Therapeutics Reports First Quarter 2021 Financial Results and Recent Highlights
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

